Monopar Therapeutics announced a net loss of $6.2 million for Q3 2026, reflecting increased R&D and administrative expenses as it advances ALXN1840, a novel treatment for Wilson disease. The company is progressing with the FDA New Drug Application (NDA) submission for ALXN1840, expected to complete soon, and has secured $129.4 million in cash to fund operations through March 2028. Clinical data presented highlight ALXN1840's safety and efficacy, supporting its potential as a first-in-class therapy for Wilson disease, a rare genetic disorder causing toxic copper buildup. Monopar also appointed a new EVP for Medical Affairs to lead regulatory and commercial preparations.
Monopar Therapeutics' Q3 2026 financial results provide context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 12, 2026 19:11 WIB: Among 150 priced health-sector US stocks, 91 rose and 53 fell today. Notably, MRVI rose 3.12% to USD 7.94 with a typical hold time of 18 days and a Pluang order activity skewed 55% Sell / 45% Buy, contrasting with TWST which dropped 3.12% to USD 118.77 but saw 100% Buy orders over 27 days typical hold. INO also fell 3.05% to USD 1.43, with 58% Sell orders and a longer typical hold time of 41 days.
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
Glider has introduced a global investing platform for tokenized stocks that operates permissionlessly, bypassing the SEC's Tokenized Securities Venues (TSVs) which 50 public companies recently rejected. Backed by major investors like a16z and Coinbas...
Tilray Brands announced that its subsidiaries 10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing are now the official craft beer partners of the Portland Trail Blazers. This partnership expands the availability of Oregon craft beers a...
Nexpu Ltd.'s subsidiary, Top Kingwin Hi Tech Inc., has finished delivering all 10,000 TK-D2C robots to Walkers Times International under a $4.8 million resale contract signed in 2025. The deliveries were completed in batches, with the final 5,000 uni...
